Investment in CBD Nutraceuticals Paying Off

Investment in CBD Nutraceuticals Paying Off

By: Tomas Ronolski - News

Thursday, October 14, 2021

Covid-19 accelerated the growth of the CBD nutraceutical market, with a growth expectation of over 22 percent. And this firm is poised to benefit. 

 PAO Group, Inc. (OTC Pink: PAOG) announced the market launch of its first CBD Nutraceutical is schedule to take place next week. The firm  expects to realize its first CBD nutraceutical product sales as soon as the fourth quarter and has already  shipped its first CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (OTC Pink: USMJ).

Revenue growth is expected to be rapid, with follow-on products lined up, adding to overall sales potential and shares were trading up 16% in afternoon trade.

Copyright © 2021 All rights reserved. Republication or redistribution of's content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Launch to Give Americans Affordable Access to Medications from Canada
Transportation Sends Durable Goods Orders Down for Second Month
Mid-Session Rally Turns Heads
Most Popular
FREE Newsletter

Back to Top